Cesira Cafiero

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Local synthesis of interferon-alpha in lupus nephritis is associated with type I interferons signature and LMP7 induction in renal tubular epithelial cells

Giuseppe Castellano, Cesira Cafiero, Chiara Divella et al. · Arthritis Research & Therapy · 2015 · 77 citations · Full text

Medicine, Immunology, Nephrology +15

Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma

Margherita Gigante, Giuseppe Lucarelli, Chiara Divella et al. · Medicine · 2015 · 57 citations · Full text

Medicine, Oncology, Pathology +17

Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: crosstalk between the immune and bone systems

Cesira Cafiero, Margherita Gigante, Giacomina Brunetti et al. · Nephrology Dialysis Transplantation · 2017 · 48 citations · Full text

Medicine, Immunology, Nephrology +17